EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML

Yandim M. Kartal; Kozanoglu I.; Ozdogu H.; Piskin O.; Ozcan M.; Saydam G.; Sahin F.; Avcu F.; Ural A.; Unal A.; Baran Y.

首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML

【24h】

EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML

机译：在新诊断和耐酪氨酸激酶抑制剂的慢性髓性白血病（CML）患者中，铈代谢基因的表达水平：CML中新靶点的发现

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 》 |2014年第1期| 共1页
作者
Yandim M. Kartal; Kozanoglu I.; Ozdogu H.; Piskin O.; Ozcan M.; Saydam G.; Sahin F.; Avcu F.; Ural A.; Unal A.; Baran Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML [J] . Yandim M. Kartal, Kozanoglu I., Ozdogu H., Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2014 ,第Suppla1期

机译：在新诊断和耐酪氨酸激酶抑制剂的慢性髓性白血病（CML）患者中，铈代谢基因的表达水平：CML中新靶点的发现
2. Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs) [J] . Djamel Aggoune, Nathalie Sorel, Marie-Laure Bonnet, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2017 ,第期

机译：骨髓间充质细胞（MSC）基因分析在慢性髓性白血病（CML）诊断患者和酪氨酸激酶抑制剂（TKI）诱导的深层分子反应中
3. Nilotinib Vs Nilotinib Plus Pegylated Interferon-alpha2b Induction and Nilotinib or Pegylated Interferon-alpha2b Maintenance Therapy for Newly Diagnosed BCR-ABL plus Chronic Myeloid Leukemia Patients in Chronic Phase: Interim Analysis of the Tiger (CML V)-Study [J] . Hochhaus Andreas, Saussele Susanne, Baerlocher Gabriela M., Blood: The Journal of the American Society of Hematology . 2018 ,第NovaelaTreatmentAppr期

机译：Nilotinib Vs Nilotinib加聚乙二醇化干扰素-α2B诱导和NiLotinib或聚乙二醇干扰素-α2B维持治疗用于新诊断的BCR-ABL加慢性慢性骨髓性白血病患者：虎（CML v） - 学生分析
4. Characterization of Leukemia-Associated Antigens in Acute and Chronic Myeloid Leukemias (AML/CML) [C] . J Greiner, M. Ringhoffer, M. Taniguchi, European Haematology Association . 2002

机译：急性和慢性骨髓白血病白血病相关抗原的表征（AML / CML）
5. Characterization of hemopoietic stem cells in chronic myeloid leukemia (CML). [D] . Udomsakdi, Chirayu. 1992

机译：慢性粒细胞白血病（CML）中造血干细胞的特征。
6. The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML) [O] . Željka Tkalčić Švabek, Marina Josipović, Ivana Horvat, 2018

机译：在新诊断的慢性粒细胞白血病（CML）病例中BCR-ABL1重排的非典型模式和酪氨酸激酶抑制剂治疗的分子细胞遗传学反应
7. PCN160 Cost-Effectiveness Of First-Line Tyrosine Kinase Inhibitors (Tkis) In Newly Diagnosed Chronic Myeloid Leukemia (Cml) Patients In Korea: Comparison Of Dasatinib (100mg), Nilotinib (600mg) And Imatinib (400mg) [O] . Shin M, Shin S, Lee JY, 2015

机译：一线酪氨酸激酶抑制剂（Tkis）在韩国新诊断的慢性粒细胞白血病（Cml）患者中的PCN160成本-效果：达沙替尼（100mg），尼洛替尼（600mg）和伊马替尼（400mg）的比较

EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML

著录项

相似文献

相关主题

期刊订阅